menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Bio-Thera, Dr. Reddy`s sign exclusive deal for Stelara and Simpon

    PRESS RELEASE

    Sandoz`s Biologic Imuldosa Receives Suppl Approval in US

    FDA

    Steqeyma, A Stelara Biosimilar, Now Available In The US

    PR NEWSWIRE

    Biocon`s Yesintek Ph3 Data Shows Efficacy In Plaque Psoriasis

    PR NEWSWIRE

    Fresenius Launches Otulfi (Ustekinumab-aauz) in U.S.

    BUSINESSWIRE

    SmithRx Adds Stelara Biosimilars To Autoimmune Program, Saving $14.5M

    BUSINESSWIRE

    J&J sues Samsung Bioepis over contract breach for Stelara

    REUTERS

    MedImpact Expands Access to Two Biosimilars for Stelara

    BUSINESSWIRE

    Biocon Biologics launches Yesintek Biosimilar to Stelara in US

    INDPHARMAPOST

    Samsung Bioepis Launches PYZCHIVA, Stelara Biosimilar In U.S.

    BUSINESSWIRE

    Sandoz launches biosimilar Pyzchiva in the US

    GLOBENEWSWIRE

    Europe approves Biocon Biologics` Ustekinumab Biosimilar

    INDPHARMAPOST

    Formycon Presents Ustekinumab Biosimilar FYB202 Data at ECCO

    PHARMAWEB

    J&J upholds sales growth confidence as Stelara biosims file in

    FIERCE PHARMA

    Japan Health Authority approves Biocon Ustekinumab BS

    INDIANPHARMAPOST

    Bio-Thera with Tabuk to Commercialize Stelara in Saudi Arabia

    PRNEWSWIRE

    Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA

    BUSINESSWIRE

    FDA approves Celltrion`s Steqeyma, a biosimilar to Stelara

    PRNEWSWIRE

    Celltrion`s Biologic Stqeyma Receives Suppl Approval in US

    FDA

    Accord Healthcare Receives Positive CHMP Opinion for Imuldosa

    PR NEWSWIRE

    Alvotech`s Biologic Selarsi (Ustekinumab) Receives Approval in US

    FDA

    Lilly reports Ph 3 study of mirikizumab compared to ustekinumab for Crohn

    PR NEWSWIRE

    US FDA Approves Dong-A ST’s Imuldosa, a Biosimilar to Stelara

    BUSINESSWIRE

    Accord`s Biologic Imuldosa (Ustekinumab) Receives Suppl Approval in US

    FDA

    Fresenius & Formycon Receive FDA Approval For Biosimilar Otulfi

    BUSINESSWIRE

    Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US

    FDA

    Samsung Bioepis`s Eksunbi (ustekinumab) Receives Approval in Europe

    EMA

    Celltrion`s Steqeyma (ustekinumab) Receives Approval in Europe

    EMA

    EC Approves Celltrion`s SteQeyma For Multiple Inflammatory Diseases

    BUSINESSWIRE

    Teva Reports Strong Q2 Growth, Raises 2024 Guidance

    GLOBENEWSWIRE

    Sandoz Launches Biosimilar Pyzchiva For Chronic Inflammatory Diseases

    GLOBENEWSWIRE

    STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In Europe

    PHARMABIZ

    STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU

    GLOBENEWSWIRE

    Amgen`s Wezenla (ustekinumab) Receives Approval in Europe

    EMA

    J&J beats Wall St estimates on strong drug sales ahead of Stelara competition

    REUTERS

    Samsung Bioepis’ PYZCHIVA Approved by FDA as Biosimilar of Stelara

    CONTRACT PHARMA

    FDA approves biosimilar Pyzchiva (Ustekinumab-ttwe), to be commercialized in US

    GLOBENEWSWIRE

    FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar

    GLOBENEWSWIRE

    Samsung Bioepis` Biologic Pyzchiva (ustekinumab-ttwe) Receives Approval in US

    FDA

    TREMFYA Studies Show Potential For SC And IV Induction As IL-23 Inhibitor

    PR NEWSWIRE

    Alvotech and STADA add to strategic alliance through denosumab partnership

    PRESS RELEASE

    Colorado drug review board finds J&J`s Stelara unaffordable

    FIERCE PHARMA

    Rani Oral Biosimilar Ustekinumab Data At DDW 2024

    GLOBENEWSWIRE

    Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates

    REUTERS

    Sandoz`s Ustekinumab Biosimilar Pyzchiva Approved In EU

    GLOBENEWSWIRE

    Alvotech and Teva gain FDA approval of Selarsdi for psoriasis

    PHARMACEUTICAL TECHNOLOGY

    Alvotech USA`s Biologic Selarsdi (ustekinumab-aekn) Receives Approval In US

    FDA

    Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™

    BUSINESSWIRE

    Centocor`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.

    FDA

    Janssen-Cilag`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.

    FDA

    Biocon Biologics gears up to challenge Stelara in the US

    FIERCE PHARMA

    Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar

    GLOBENEWSWIRE

    J&J profit edges past Street view after deals delay Stelara competition

    REUTERS

    STADA and Alvotech Secure Approval for Uzpruvo

    GLOBENEWSWIRE

    FDA Accepts for Review BLA for DMB-3115 of Dong-A ST

    BUSINESSWIRE

    J&J, Samsung Bioepis ink Stelara biosimilar settlement

    FIERCE PHARMA

    Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki

    GLOBENEWSWIRE

    STADA and Alvotech receive positive CHMP opinion for ustekinumab biosimilar

    GLOBENEWSWIRE

    HHS says Stelara may be deselected from Medicare negotiations

    ENDPTS

    FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.